FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Morphine sulphate 20mg suppositories 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Morphine sulphate 20mg suppositories (Unichem Plc) 12 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ebetrex 7.5mg/0.75ml solution for injection pre-filled syringes (Sandoz Ltd) 1 pre-filled disposable injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ebetrex 15mg/1.5ml solution for injection pre-filled syringes (Sandoz Ltd) 1 pre-filled disposable injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Metoject 7.5mg/0.75ml solution for injection pre-filled syringes (medac UK) 1 pre-filled disposable injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Morphine sulphate 20mg suppositories (Special Order) 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Morphine sulphate 20mg suppositories (Martindale Pharmaceuticals Ltd) 12 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metoject 15mg/1.5ml solution for injection pre-filled syringes (medac UK) 1 pre-filled disposable injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ebetrex 10mg/1ml solution for injection pre-filled syringes (Sandoz Ltd) 1 pre-filled disposable injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Metoject 10mg/1ml solution for injection pre-filled syringes (medac UK) 1 pre-filled disposable injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Morphine sulphate 20mg suppositories (A A H Pharmaceuticals Ltd) 12 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (A A H Pharmaceuticals Ltd) 14 dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely cortisone acetate 25 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cortisone 25mg tablets (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cortisone 25mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cortisone 25mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cortisone 25mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cortisone 25mg tablets 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cortisone 25mg tablets (sanofi-aventis) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cortisone 25mg tablets (Unichem Plc) 56 tablet 4 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cortisone 25mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cortisone 25mg tablets (sanofi-aventis) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cortisone 25mg tablets (A A H Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely sulfasalazine 50 milligram/1 milliliter conventional release oral suspension VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Salazopyrin 250mg/5ml suspension (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Salazopyrin 250mg/5ml suspension (Pfizer Ltd) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sulfasalazine 250mg/5ml oral suspension (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Artelac Single Dose Unit 0.32% eye drops 0.5ml unit dose (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovonex 50micrograms/g ointment (LEO Pharma) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Artelac Single Dose Unit 0.32% eye drops 0.5ml unit dose (Doncaster Pharmaceuticals Ltd) 30 unit dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely dydrogesterone 10 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours patches 30 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dydrogesterone 10mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dydrogesterone 10mg tablets 42 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Androderm 5mg/24hours transdermal patches (Imported (United States)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dydrogesterone 10mg tablets 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dydrogesterone 10mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Duphaston 10mg tablets (Solvay Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dydrogesterone 10mg tablets 14 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Duphaston HRT 10mg tablets (Solvay Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Andropatch 5mg/24hours patches (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patches (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patches 1 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Duphaston HRT 10mg tablets (Solvay Healthcare Ltd) 42 tablet 3 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patches (Special Order) 1 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Duphaston 10mg tablets (Solvay Healthcare Ltd) 60 tablet 4 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Andropatch 5mg/24hours patches (GlaxoSmithKline) 30 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dydrogesterone 10mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Duphaston 10mg tablets (Solvay Healthcare Ltd) 14 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Androderm 5mg/24hours transdermal patches (Imported (United States)) 30 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 300,000units/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 600,000units/2ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 600,000units/2ml solution for injection ampoules (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 600,000units/2ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 300,000units/1ml solution for injection ampoules 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 600,000units/2ml solution for injection ampoules 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 300,000units/1ml solution for injection ampoules 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 300,000units/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 600,000units/2ml solution for injection ampoules (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 300,000units/1ml solution for injection ampoules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 300,000units/1ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 600,000units/2ml solution for injection ampoules 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 600,000units/2ml solution for injection ampoules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 300,000units/1ml solution for injection ampoules (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 300,000units/1ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 300,000units/1ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 1ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 600,000units/2ml solution for injection ampoules (Special Order) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 600,000units/2ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 2ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 600,000units/2ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) 10 ampoule 10 x 2ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 300,000units/1ml solution for injection ampoules (Special Order) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 300,000units/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 600,000units/2ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 2ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely tetracycline 250 milligram/1 each conventional release oral capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Tetracycline 250mg capsules 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Achromycin 250mg capsules (Wyeth Laboratories) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetracycline 250mg capsules 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetracycline 250mg capsules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Achromycin 250mg capsules (Wyeth Laboratories) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetracycline 250mg capsules (Special Order) 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Sandoz Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Sandoz Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely oxprenolol hydrochloride 20 milligram/1 each conventional release oral tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely oxprenolol hydrochloride 40 milligram/1 each conventional release oral tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets 56 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxprenolol 40mg tablets 56 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Trasicor 20mg tablets (Amdipharm) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Trasicor 40mg tablets (Amdipharm) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxprenolol 40mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets (Alliance Healthcare (Distribution) Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxprenolol 40mg tablets (Alliance Healthcare (Distribution) Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Trasicor 40mg tablets (Amdipharm) 56 tablet 4 x 14 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Trasicor 20mg tablets (Amdipharm) 56 tablet 4 x 14 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxprenolol 40mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxprenolol 20mg tablets (A A H Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 49 of 86 Next End


This concept is not in any reference sets

Back to Start